[Inhibitors of reverse serotonin uptake and of specific imipramine binding in human blood plasma].
Human blood plasma contains low-molecular substances that inhibit in a dose-dependent manner both high-affinity specific binding of imipramine and reverse serotonin uptake by platelets. Incubation of human blood plasma with alumina was made use of to extract and study these imipramine-like inhibitors. The extract obtained from human blood plasma inhibited imipramine binding and reverse uptake of serotonin with median inhibitory concentrations of 0.18 +/- 0.1 and 0.36 +/- 0.15 mg/ml, respectively. After gel chromatography on Biogel P-2 the elution profile of the extract showed 2 major peaks of reverse serotonin uptake and imipramine binding inhibition and 3 additional peaks of reverse serotonin uptake inhibition, which did not have any considerable effect on imipramine specific binding. It is assumed that endogenous inhibitors of imipramine binding and reverse serotonin uptake are involved in the development of affective disorders.
D000328:Adult; D002850:Chromatography, Gel; D006801:Humans; D007099:Imipramine / Q000037:antagonists & inhibitors* / Q000097:blood; D011485:Protein Binding / Q000187:drug effects; D012588:Scintillation Counting; D012702:Serotonin Antagonists / Q000097:blood*; D013057:Spectrum Analysis; D014462:Ultrafiltration
D012702:Serotonin Antagonists; D007099:Imipramine
Ingibitory obratnogo zakhvata serotonina i spetsificheskogo sviazyvaniia imipramina v plazme krovi cheloveka.